Glow Blend 70mg

Glow Blend 70mg

Total Price
$1040.00
Discounted
$832.00
Vials
5
You Save
$208.00
20% OFF
Only $166.40 per vial— final price per vial after savings
Bulk pricing applied
📈 Upgrade to 10 vials and save an extra $416.00 vs buying 5 — nearly 5 free vials.
Selected Purchase Option:
  • 99%+ HPLC PurityIndependently verified by accredited US laboratory
  • Endotoxin-ScreenedLAL tested, LPS-free, endotoxin report available
  • GMP-Certified ManufacturingUSA facility, ISO 9001:2015
  • Lyophilized for StabilityShipped cold-packed, intact for reconstitution
Molecular Weight
Third Party Tested
Application
For Research Use only
Form
Lyophilized Powder
Storage
-20°C Long Term
Purity (HPLC)
99%+ Third Party Verified
Manufacture
USA / GMP

Description

The BPC-157 / TB-500 / GHK-Cu blend is a standardized, multi-component research preparation combining three structurally distinct peptides in a single lyophilized vial. BPC-157 is a synthetic pentadecapeptide derived from a sequence found in human gastric juice; TB-500 is a synthetic analogue of the actin-sequestering protein Thymosin Beta-4; and GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring tripeptide-copper complex first isolated from human plasma. Together, the three components span different molecular weight ranges and physicochemical profiles, making the blend a useful tool for investigators studying overlapping biological pathways in a single experimental system.

The preparation is formulated at fixed quantities — 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu — for a combined lyophilized mass of 70 mg per vial. A pre-blended, proportionally fixed format reduces the variability that can arise when researchers independently weigh and combine individual peptides before each experiment, supporting greater consistency across replicate studies. GHK-Cu's copper-chelating character and distinct electrostatic surface properties are understood to contribute to the physicochemical compatibility of the three peptides in the co-lyophilized matrix, allowing them to coexist in a single solid-phase preparation without compromising the integrity of the other components.

Researchers select this blend to probe biological processes in which the three peptides may act on related or complementary pathways. BPC-157 has been studied in preclinical models for its interactions with growth factor signaling and angiogenic cascades. TB-500's actin-binding activity has made it a subject of inquiry in studies examining cell migration and cytoskeletal dynamics. GHK-Cu has attracted attention in investigations of extracellular matrix remodeling, antioxidant enzyme activity, and gene expression regulation. The combined format is particularly relevant for experimental designs that require simultaneous exposure to all three peptides under controlled, reproducible conditions.

References

No external sources were cited in this section.

Certificate of Analysis

Every batch is independently tested before it ships. Full documentation available for every product.

Lab Analysis — Vangaurd Testing Laboratory
HPLC Purity99%+ — Passes ≥99%
Mass Spectrometry IdentityConfirmed
Endotoxin (LAL)<1.0 EU/mg — LPS-Free
Sterility (USP)No growth detected
AppearanceLyophilized powder
Sequence ConfirmationAll confirmed
Content Quantification±0.2% — Within spec
Testing Lab AccreditationISO/IEC 17025:2017
ManufactureGMP / ISO 9001:2015
Analysis Date2026

Certificate of Analysis

Verified
99%+
HPLC Purity · This Batch
  • HPLC Separation: Exceeds 99% minimum
  • Mass Spectrometry: Molecular identity confirmed
  • Endotoxin Screen: <1.0 EU/mg — LPS-Free, LAL tested
  • Sterility: No microbial growth — USP compliant
  • Content: ±0.2% — accurate fill weight

Frequently Asked Questions

Customers also bought